[HTML][HTML] Drug-induced acute angle-closure glaucoma: a review

MC Yang, KY Lin - Journal of current glaucoma practice, 2019 - ncbi.nlm.nih.gov
Aim Our goal is to review current literature regarding drug-induced acute angle-closure
glaucoma (AACG) and provide ophthalmologists and general practitioners with a thorough …

NLRP12 collaborates with NLRP3 and NLRC4 to promote pyroptosis inducing ganglion cell death of acute glaucoma

H Chen, Y Deng, X Gan, Y Li, W Huang, L Lu… - Molecular …, 2020 - Springer
Background Acute glaucoma, characterized by a sudden elevation in intraocular pressure
(IOP) and retinal ganglion cells (RGCs) death, is a major cause of irreversible blindness …

Iridotomy to slow progression of visual field loss in angle‐closure glaucoma

G Gazzard - Cochrane Database of Systematic Reviews, 2023 - cochranelibrary.com
Background Primary angle‐closure glaucoma is a type of glaucoma associated with a
physically obstructed anterior chamber angle. For example, contact between the iris and …

Deep learning algorithms to isolate and quantify the structures of the anterior segment in optical coherence tomography images

TH Pham, SK Devalla, A Ang, ZD Soh… - British Journal of …, 2021 - bjo.bmj.com
Background/Aims Accurate isolation and quantification of intraocular dimensions in the
anterior segment (AS) of the eye using optical coherence tomography (OCT) images is …

[HTML][HTML] Resveratrol alleviates retinal ischemia-reperfusion injury by inhibiting the NLRP3/gasdermin D/Caspase-1/Interleukin-1β pyroptosis pathway

Z Xie, Q Ying, H Luo, M Qin, Y Pang… - … & Visual Science, 2023 - iovs.arvojournals.org
Purpose: The purpose of this study is to investigate the anti-pyroptotic effect of resveratrol in
the context of ischemia-reperfusion (I/R)-induced retinal injury, with a particular focus on …

[HTML][HTML] Lowering of intraocular pressure after phacoemulsification in primary open-angle and angle-closure glaucoma: Correlation with lens thickness

MA Kader, A Pradhan, AG Shukla… - Indian Journal of …, 2022 - journals.lww.com
Purpose: To assess anterior chamber configuration changes during phacoemulsification in
primary angle-closure suspect (PACS/PAC) and primary open-angle glaucoma (POAG) …

An overview of treatment methods for primary angle closure

F Anwar, A Turalba - Seminars in Ophthalmology, 2017 - Taylor & Francis
Background: Glaucoma is the second leading cause of blindness in the world. Angle closure
glaucoma accounts for 25% of all glaucoma, with Asia having the highest rate. Angle closure …

Determination of anterior segment changes with Pentacam after phacoemulsification in eyes with primary angle‐closure glaucoma

Q Zhao, N Li, X Zhong - Clinical & experimental ophthalmology, 2012 - Wiley Online Library
Background: To investigate changes of anterior segment morphology in primary angle‐
closure glaucoma after phacoemulsification using the Pentacam system. Design …

Efficacy of Micropulse Laser Cyclophotocoagulation Therapy in Primary Angle Closure Glaucoma

D Chauhan, N Midha, K Mahalingam… - Journal of …, 2023 - journals.lww.com
Purpose: The purpose of this study was to evaluate the efficacy and safety of micropulse
trans-scleral cyclophotocoagulation (MP-TSCPC) in PACG. Patients and Methods: Thirty …

[HTML][HTML] The timing of goniosynechialysis in treatment of primary angle-closure glaucoma combined with cataract

J Yu, M Sun, Y Wei, X Cai, C He, X An, J Ye - Molecular Vision, 2012 - ncbi.nlm.nih.gov
Purpose To compare the clinical effects of phacoemulsification (PHACO) combined with
goniosynechialysis (GSL) at different times in the treatment of primary angle-closure …